#MedCase - Progressive loss of glycemic control in a 52-year-old man following stable #T2D management on metformin and #DPP4 inhibitor combination therapy.
Could acquired incretin resistance be responsible for treatment failure?
👉️ buff.ly/cE5rJD9
#MedSky
Progressive loss of glycemic control in a 52-year-old man following stable disease management on metformin and DPP-4 inhibitor combination therapy. Could acquired incretin resistance be responsible…